Cobbold Stephen P, Nolan Kathleen F, Graca Luis, Castejon Raquel, Le Moine Alain, Frewin Mark, Humm Susan, Adams Elizabeth, Thompson Sara, Zelenika Diana, Paterson Alison, Yates Stephen, Fairchild Paul J, Waldmann Herman
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Immunol Rev. 2003 Dec;196:109-24. doi: 10.1046/j.1600-065x.2003.00078.x.
Transplantation tolerance can be induced in adult rodents using monoclonal antibodies against coreceptor or costimulation molecules on the surface of T cells. There are currently two well-characterized populations of T cells, demonstrating regulatory capacity: the "natural" CD4+CD25+ T cells and the interleukin (IL)-10-producing Tr1 cells. Although both types of regulatory T cells can induce transplantation tolerance under appropriate conditions, it is not clear whether either one plays any role in drug-induced dominant tolerance, primarily due to a lack of clear-cut molecular or functional markers. Similarly, although dendritic cells (DCs) can be pharmacologically manipulated to promote tolerance, the phenotype of such populations remains poorly defined. We have used serial analysis of gene expression (SAGE) with 29 different T-cell and antigen-presenting cell libraries to identify gene-expression signatures associated with immune regulation. We found that independently derived, regulatory Tr1-like clones were highly concordant in their patterns of gene expression but were quite distinct from CD4+CD25+ regulatory T cells from the spleen. DCs that were treated with the tolerance-enhancing agents IL-10 or vitamin D3 expressed a gene signature reflecting a functional specification in common with the most immature DCs derived from embryonic stem cells.
使用针对T细胞表面共受体或共刺激分子的单克隆抗体,可在成年啮齿动物中诱导移植耐受。目前有两种特征明确的具有调节能力的T细胞群体:“天然”CD4+CD25+T细胞和产生白细胞介素(IL)-10的Tr1细胞。虽然这两种调节性T细胞在适当条件下都能诱导移植耐受,但尚不清楚它们是否在药物诱导的显性耐受中发挥作用,主要原因是缺乏明确的分子或功能标志物。同样,虽然树突状细胞(DC)可通过药理学方法进行调控以促进耐受,但此类细胞群体的表型仍不清楚。我们利用基因表达序列分析(SAGE)对来自于29个不同T细胞和抗原呈递细胞文库进行分析,以鉴定与免疫调节相关的基因表达特征。我们发现,独立衍生的调节性Tr1样克隆在基因表达模式上高度一致,但与来自脾脏的CD4+CD25+调节性T细胞明显不同。用增强耐受的药物IL-10或维生素D3处理的DC,其表达的基因特征反映出与源自胚胎干细胞的最不成熟DC具有共同功能特性。